Treatment of predialysis patients with recombinant human erythropoietin.
Koene
R A
RA
Department of Medicine, University Hospital, Nijmegen, The Netherlands.
Frenken
L A
LA
Wetzels
J F
JF
Sluiter
H E
HE
Schrijver
G
G
Verberckmoes
R
R
Michielsen
P
P
D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy / Q000628:therapy; D006435:Renal Dialysis
D006454:Hemoglobins; D004921:Erythropoietin